These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22990206)

  • 1. Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.
    Kaiser NC; Melrose RJ; Liu C; Sultzer DL; Jimenez E; Su M; Monserratt L; Mendez MF
    Am J Alzheimers Dis Other Demen; 2012 Nov; 27(7):520-9. PubMed ID: 22990206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease.
    Tondo G; Iaccarino L; Caminiti SP; Presotto L; Santangelo R; Iannaccone S; Magnani G; Perani D
    Alzheimers Res Ther; 2020 Apr; 12(1):50. PubMed ID: 32354345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.
    Joubert S; Gour N; Guedj E; Didic M; Guériot C; Koric L; Ranjeva JP; Felician O; Guye M; Ceccaldi M
    Cortex; 2016 Jan; 74():217-32. PubMed ID: 26694580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease.
    Aziz AL; Giusiano B; Joubert S; Duprat L; Didic M; Gueriot C; Koric L; Boucraut J; Felician O; Ranjeva JP; Guedj E; Ceccaldi M
    Neurobiol Aging; 2017 Jun; 54():22-30. PubMed ID: 28314160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
    Habeck C; Risacher S; Lee GJ; Glymour MM; Mormino E; Mukherjee S; Kim S; Nho K; DeCarli C; Saykin AJ; Crane PK;
    Brain Imaging Behav; 2012 Dec; 6(4):568-83. PubMed ID: 23179062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid deposition in early onset versus late onset Alzheimer's disease.
    Cho H; Seo SW; Kim JH; Suh MK; Lee JH; Choe YS; Lee KH; Kim JS; Kim GH; Noh Y; Ye BS; Kim HJ; Yoon CW; Chin J; Na DL
    J Alzheimers Dis; 2013; 35(4):813-21. PubMed ID: 23507771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
    Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
    J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: A five-year longitudinal study.
    Kim SH; Seo SW; Yoon DS; Chin J; Lee BH; Cheong HK; Han SH; Na DL
    Dement Geriatr Cogn Disord; 2010; 29(3):213-23. PubMed ID: 20332639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.
    Visser D; Verfaillie SCJ; Wolters EE; Coomans EM; Timmers T; Tuncel H; Boellaard R; Golla SSV; Windhorst AD; Scheltens P; van der Flier WM; van Berckel BNM; Ossenkoppele R
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1951-1963. PubMed ID: 34997294
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Vanhoutte M; Semah F; Rollin Sillaire A; Jaillard A; Petyt G; Kuchcinski G; Maureille A; Delbeuck X; Fahmi R; Pasquier F; Lopes R
    Neurobiol Aging; 2017 Nov; 59():184-196. PubMed ID: 28882421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease.
    Ballarini T; Iaccarino L; Magnani G; Ayakta N; Miller BL; Jagust WJ; Gorno-Tempini ML; Rabinovici GD; Perani D
    Hum Brain Mapp; 2016 Dec; 37(12):4234-4247. PubMed ID: 27412866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
    Zahn R; Juengling F; Bubrowski P; Jost E; Dykierek P; Talazko J; Huell M
    Psychiatry Res; 2004 Dec; 132(2):159-72. PubMed ID: 15598550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold?
    Palasí A; Gutiérrez-Iglesias B; Alegret M; Pujadas F; Olabarrieta M; Liébana D; Quintana M; Álvarez-Sabín J; Boada M
    J Neurol; 2015 May; 262(5):1238-46. PubMed ID: 25791224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
    Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization.
    Bergeron D; Sellami L; Poulin S; Verret L; Bouchard RW; Laforce R
    Dement Geriatr Cogn Disord; 2020; 49(5):518-525. PubMed ID: 33207355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.
    Rabinovici GD; Furst AJ; Alkalay A; Racine CA; O'Neil JP; Janabi M; Baker SL; Agarwal N; Bonasera SJ; Mormino EC; Weiner MW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ
    Brain; 2010 Feb; 133(Pt 2):512-28. PubMed ID: 20080878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.